USFDA conducts GMP inspection at Indoco Remedies’ Goa Facility

01 Mar 2023 Evaluate

The United States Food and Drug Administration (USFDA) has conducted GMP inspection at Indoco Remedies’ Plant II (Sterile Facility) and Plant III (OSD Facility) at Goa. The inspection was conducted from February 20, 2023 to February 28, 2023.

The USFDA has issued Form 483 with four observations, which will be addressed within stipulated time. The company is committed to maintain compliances across all its facilities with cGMP quality standards at all times.

Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.

Indoco Remedies Share Price

210.20 -4.75 (-2.21%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×